Biocon

Bengaluru, India Founded: 1978 • Age: 48 yrs
Drug RD services are provided for multiple therapeutic areas.
Request Access

About Biocon

Biocon is a company based in Bengaluru (India) founded in 1978 by Kiran Mazumdar Shaw.. The company has 4,020 employees as of April 08, 2024. Biocon has completed 2 acquisitions, including Axicorp and Nobex Corp. Biocon offers products and services including Biosimilars and Generics.

  • Headquarter Bengaluru, India
  • Employees 4020 as on 08 Apr, 2024
  • Founders Kiran Mazumdar Shaw
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Biocon Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $1.78 B (USD)
    3.45
    as on Mar 31, 2024
  • Net Profit
    $118.34 M (USD)
    -0.9
    as on Mar 31, 2024
  • EBITDA
    $389.6 M (USD)
    -20.59
    as on Mar 31, 2024
  • Latest Funding Round
    $300 M (USD), Post-IPO

    Apr 25, 2023

  • Investors
  • Employee Count
    4020

    as on Apr 08, 2024

  • Investments & Acquisitions
    Axicorp

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Biocon

Biocon is a publicly listed company on the NSE with ticker symbol BIOCON in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: BIOCON . Sector: Health technology · India

Products & Services of Biocon

Biocon offers a comprehensive portfolio of products and services, including Biosimilars and Generics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Biosimilars are developed as cost-effective alternatives to biologic drugs for various therapeutic areas

Generics are manufactured for key therapeutic areas to provide affordable medication options

People of Biocon
Headcount 5000-10000
Employee Profiles 130
Board Members and Advisors 8
Employee Profiles
People
Gladson Varghese
Executive
People
Thangadurai B
Executive Engineer
People
Siddharth Mittal
Managing Director & CEO
People
Jacqueline Paiva
Head Marketing

Unlock access to complete

Board Members and Advisors
people
Kiran Mazumdar-shaw
Executive Chairperson, Biocon
people
John Shaw
Vice Chairman and Non-Executive Director
people
Vijay Kuchroo
Independent Director
people
Daniel M. Bradbury
Independent Director

Unlock access to complete

Funding Insights of Biocon

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $300.0M
  • First Round
  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Post-IPO - Biocon Valuation

investors

Feb, 2023 Amount Post-IPO - Biocon Valuation

investors

Jan, 2021 Amount Post-IPO - Biocon Valuation

investors

ADQ
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biocon

Biocon has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Goldman Sachs, Kotak Mahindra Bank and Tata Capital Growth Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
ADQ is recognized as a leading sovereign investor focused on sustainable economic transformation in Abu Dhabi.
Founded Year Domain Location
Investment banking services are delivered across multiple financial sectors.
Founded Year Domain Location
Growth capital fund sponsored by the Tata group, focusing on investments and portfolio management.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biocon

Biocon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Axicorp and Nobex Corp. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
OTC drugs are manufactured by Axicorp in Germany.
2002
Blog on legal & personal attorney related topics
1993
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Biocon

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biocon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biocon

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biocon

Frequently Asked Questions about Biocon

When was Biocon founded?

Biocon was founded in 1978 and raised its 1st funding round 25 years after it was founded.

Where is Biocon located?

Biocon is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Who is the current CEO of Biocon?

Siddharth Mittal is the current CEO of Biocon.

How many employees does Biocon have?

As of Apr 08, 2024, the latest employee count at Biocon is 4,020.

What is the annual revenue of Biocon?

Annual revenue of Biocon is $1.78B as on Mar 31, 2024.

What does Biocon do?

Biocon was founded in 1978 in Bengaluru, India, within the biotechnology sector. Drug research and development services are offered across various therapeutic areas. Additional operations include research on gene therapy, API development, generic formulations, quality control, and scientific services. The company supports pharmaceutical innovation through these specialized offerings in the Indian market.

What products or services does Biocon offer?

Biocon offers Biosimilars and Generics.

Is Biocon publicly traded?

Yes, Biocon is publicly traded on NSE under the ticker symbol BIOCON.

How many acquisitions has Biocon made?

Biocon has made 2 acquisitions, including Axicorp, and Nobex Corp.

Who are Biocon's investors?

Biocon has 6 investors. Key investors include Goldman Sachs, Kotak Mahindra Bank, Tata Capital Growth Fund, Serum Life Sciences, and ADQ.

What is Biocon's ticker symbol?

The ticker symbol of Biocon is BIOCON on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available